Annals of Emergency Medicine
Volume 39, Issue 2 , Pages 131-138 , February 2002

B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea

Received 6 April 2001 ,Revised 27 August 2001 ,Accepted 30 October 2001.

References 

  1. Gibler WB, Runyon JP, Levy RC, et al.  A rapid diagnostic and treatment center for patients with chest pain in the emergency department. Ann Emerg Med. 1995;25:1–8
  2. Roberts R, Kleiman NS. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a ‘new diagnostic mind-set.'. Circulation. 1994;89:872–881
  3. Kost GJ, Kirk JD, Omand K. A strategy for the use of cardiac injury markers (troponin I and T, creatine kinase-MB mass and isoforms, and myoglobin) in the diagnosis of acute myocardial infarction. Arch Pathol Lab Med. 1998;122:245–251
  4. Ng SM, Krishnaswamy P, Morissey R, et al.  Ninety-minute accelerated critical pathway for chest pain evaluation. Am J Cardiol. 2001;88:611–617
  5. Marantz PR, Kaplan MC, Alderman MH. Clinical diagnosis of congestive heart failure in patients with acute dyspnea. Chest. 1990;97:776–781
  6. McNamara RM, Kelly JJ. Cost of care in the emergency department: impact of an emergency medicine residency program. Ann Emerg Med. 1992;21:956–962
  7. Nakagawa O, Ogawa Y, Itoh H, et al.  Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: evidence for BNP as an “emergency” cardiac hormone against ventricular overload. J Clin Invest. 1995;96:1280–1287
  8. Maeda K, Tsutamoto T, Wada A, et al.  Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 1998;135:825–832
  9. Clerico A, Iervasi G, Del Chicca M, et al.  Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure. J Endocrinol Invest. 1998;21:170–179
  10. Muders F, Kromer EP, Griese DP, et al.  Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J. 1997;134:442–449
  11. Tsutamoto T, Wada A, Maeda K, et al.  Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509–516
  12. Wallen T, Landahl S, Hedner T, et al.  Brain natriuretic peptide predicts mortality in the elderly. Heart. 1997;77:264–267
  13. Cheng VL, Kazanegra R, Garcia A, et al.  A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386–391
  14. Dao Q, Krishnaswamy P, Kazanegra R, et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting. J Am Coll Cardiol. 2001;37:379–385
  15. Wieczorek S, Wu A, Christenson R, et al.  A rapid B-type natriuretic peptide (BNP) assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. Am Heart J. 2002; In press
  16. American Heart Association . Heart and Stroke Facts: 1996 Statistical Supplement. In: Dallas, TX: American Heart Association; 1996;p. 15
  17. Drumholtz HM, Chen YT, Wan Y, et al.  Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139:72–77
  18. American Journal of Cardiology/Advisory Council to Improve Outcomes Nationwide in Heart Failure . Consensus Recommendations for the Management of Chronic Heart Failure. Am J Cardiol. 1999;83(2A):1A–38A
  19. Remes J, Miettinen H, Reunanen A, et al.  Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 1991;12:315–321
  20. Struthers AD. Prospects for using a blood sample in the diagnosis of heart failure. QJM. 1995;88:303–306
  21. Haug C, Metzele A, Kochs M, et al.  Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure. Clin Cardiol. 1993;16:553–557
  22. Porter JG, Arfsten A, Palasi T, et al.  Cloning of cDNA encoding porcine brain natriuretic peptide. J Biol Chem. 1989;264:6689–6692
  23. Davis M, Espiner E, Richards G, et al.  Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet. 1994;343:440–444
  24. Troughton RW, Frampton CM, Yandle TG, et al.  Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126–1130
  25. Kikuta K, Yasue H, Yoshimura M, et al.  Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J. 1996;132:101–107
  26. Omland T, Bonarjee VVS, Lie RT, et al.  Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. Am J Cardiol. 1995;76:230–235
  27. Nagaya N, Nishikimi T, Okano Y, et al.  Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol. 1998;32:202–208

☆ Author contributions are provided at the end of this article.

☆☆ Dr. Maisel does minimal consulting, research support, and receives honoraria from BioSite, maker of the assay used in this study.

★ This study was funded in part by BioSite.

★★ Address for reprints: Alan S. Maisel, MD, Veterans Affairs Medical Center, Cardiology 111-A, 3350 La Jolla Village Drive, San Diego, CA 92161; 619-552-8585 ext. 7344,fax 858-552-7490; E-mail amaisel@ucsd.edu .

PII: S0196-0644(02)03009-3

doi: 10.1067/mem.2002.121483

Annals of Emergency Medicine
Volume 39, Issue 2 , Pages 131-138 , February 2002

Article Tools

* Image Usage & Resolution